D
WPD Pharmaceuticals Inc. WBIO
CNSX
Recommendation
Sell
Prev Close
$0.19
Volume
--
Avg Vol (90D)
1,057
Market Cap
$614.71K
Dividend & Yield
--
52-Week Range
$0.125 - $0.875
P/E (TTM)
--
EPS (TTM)
-$0.0016
My Lists My Alerts
Weiss Ratings WBIO - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Rating D
Reward Index Weak
Risk Index Very Weak
Risk Grade E+
Reward Grade D
Rating Factors WBIO - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Dividend Index --
Growth Index Very Weak
Efficiency Index Fair
Solvency Index Very Weak
Total Return Index Very Weak
Volatility Index Weak
Beta / Standard Deviation WBIO - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Beta -0.73
Price History WBIO - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
7-Day Total Return -97.37%
30-Day Total Return -96.00%
60-Day Total Return -96.00%
90-Day Total Return -96.00%
Year to Date Total Return -96.83%
1-Year Total Return -99.56%
2-Year Total Return -99.56%
3-Year Total Return -99.69%
5-Year Total Return -99.98%
52-Week High % Change -78.29%
52-Week Low % Change 52.00%
Price WBIO - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
52-Week High Price $0.88
52-Week Low Price $0.13
52-Week Low Price (Date) Jun 06, 2024
52-Week High Price (Date) Jun 04, 2024
Valuation WBIO - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Market Cap 614.71K
Enterprise Value 880.77K
Price/Earnings (TTM) --
Earnings Per Share (TTM) 0.00
Earnings Per Share Growth -100.17%
Price/Earnings To Growth --
Price/Sales (TTM) --
Price/Book (Q) -1.91
Enterprise Value/Revenue (TTM) --
Price $0.01
Enterprise Value/EBITDA (TTM) -4.25
Enterprise Value/EBIT -4.13
Market Cap Category Nano Cap
Dividends and Shares WBIO - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Shares Outstanding 4.63M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info WBIO - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Phone Number --
Address 700 – 595 Burrard Street Vancouver, BC V7X 1S8
Website www.wpdpharmaceuticals.com
Country Canada
Year Founded --
Profitability WBIO - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Operating Margin (TTM) --
Profit Margin --
Management Effectiveness WBIO - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Return on Assets -71.19%
Return on Equity --
Income Statement WBIO - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Revenue (TTM) --
Total Revenue (TTM) --
Revenue Per Share --
Gross Profit (TTM) --
EBITDA (TTM) -207.40K
EBIT (TTM) -213.40K
Net Income (TTM) -6.00K
Net Income Avl. to Common (TTM) -6.00K
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) 154.38%
EPS Diluted (TTM) 0.00
EPS Diluted Growth (Q YOY) 153.19%
Balance Sheet WBIO - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash and Short-Term Inv. (Q) 6.90K
Cash Per Share (Q) $0.00
Total Current Assets (Q) 42.20K
Total Preferred Equity (Q) --
Total Equity (Q) -460.60K
Current Ratio (Q) 0.105
Book Value Per Share (Q) -$0.10
Total Assets (Q) 216.50K
Total Current Liabilities (Q) 403.00K
Total Debt (Q) 289.30K
Total Liabilities (Q) 677.20K
Total Common Equity (Q) -460.60K
Cash Flow WBIO - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash from Investing (TTM) 5.40K
Cash from Financing (TTM) 22.40K
Net Change in Cash (TTM) -99.00K
Levered Free Cash Flow (TTM) -191.90K
Cash from Operations (TTM) -126.80K
Weiss Ratings